MedPath

Multimodal Investigation of Intracranial Clot Environment

Recruiting
Conditions
Acute Ichemic Stroke
Brain Ischemia
Registration Number
NCT04421326
Lead Sponsor
University Hospital, Montpellier
Brief Summary

Analysis of peri clot blood collected at the acute phase of stroke in order to understand physiopathological mechanisms involved in the cerebrovascular damage

Detailed Description

It has been shown that immune cells accumulate around the clot at the acute phase of stroke. Leukocytes and their specific chemokines and cytokines regulation may impact cerebrovascular integrity.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Metalloproteinase 9 quantification60 months
Metalloproteinase 2 quantification60 months
Secondary Outcome Measures
NameTimeMethod
Cytokines levels60 months

Proteomic analysis of cytokines IL-1β, TNF-α, IL-6

Trial Locations

Locations (1)

University Hospital of Montpellier

🇫🇷

Montpellier, France

University Hospital of Montpellier
🇫🇷Montpellier, France
Vincent COSTALAT
Contact
0467337274
v-costalat@chu-montpellier.fr

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.